JCNN News Summaries - Japan Corporate News Network - Sankyo to Launch Osteoporosis Treatment Drug in Europe
Wednesday, December 3rd, 2008Osteoporosis Drug Protects Against Breast Cancer The osteoporosis drug raloxifene (Evista) may be just as effective as tamoxifen at reducing the risk of invasive breast cancer, according to results from the STAR clinical trial, which compared how well the…
